From owner-announce@net.bio.net Wed Nov 10 21:13:00 1999 Path: biosci!biosci!not-for-mail From: "Dr. Eric Wickstrom" Newsgroups: bionet.announce Subject: Millennium Conference on Nucleic Acid Therapeutics 8-11 January Date: 10 Nov 1999 15:13:05 -0800 Organization: BIOSCI International Newsgroups for Molecular Biology Lines: 132 Sender: daemon@net.bio.net Approved: kristoff@net.bio.net Distribution: world Message-ID: <3.0.6.32.19991109152929.00933e80@tesla.jci.tju.edu> NNTP-Posting-Host: net.bio.net Millennium Conference on Nucleic Acid Therapeutics - see http://tesla.jci.tju.edu/millennium.html 8-11 January, 2000 Clearwater Beach, Florida Conference Focus: A broad international research effort to develop nucleic acid analogs and vectors as therapeutics for cancers, chronic diseases, and microorganisms has finally led to clinical trials and the first FDA approval of a DNA drug. Great progress has occurred since the last Clearwater Beach meeting in 1991. The 2000 meeting will provide a forum whereby the most recent developments in preparing gene specific drugs and vectors, and applying those agents in preclinical and clinical trials will be shared among scientists, clinicians, and regulators from around the world. The conference is supported by the International Union of Biochemistry and Molecular Biology, the US National Institutes of Health, and biotechnology firms. Conference Design: Participants will arrive at the Hilton Clearwater Beach Resort on a Saturday, then attend plenary sessions in the morning and evening on Sunday, Monday, and Tuesday, with departure on Wednesday morning. Poster sessions will be held in the afternoons, leaving participants free to discuss mutual research interests and develop new projects. The great majority of participants are expected to stay at the hotel, and eat all their meals together. The cost of food is included in the $500 registration fee. This meeting design encourages the maximum possible interaction of participants. Participation will be limited to 300 persons. Please email additional questions to the organizer, eric@tesla.jci.tju.edu. Conference Sessions: Sunday Morning: Oligonucleotide Derivatives Dr. Maria Koziolkiewicz, Lodz Centre of Molecular & Macromolecular Studies Dr. Akira Murakami, Kyoto Institute of Technology Dr. Peter Nielsen, University of Copenhagen Dr. Barbara Shaw, Duke University Dr. James Summerton, GeneTools Dr. Valentina Zarytova, Novosibirsk Institute of Bioorganic Chemistry Sunday Evening: Diagnostic Oligonucleotide Chips Dr. Michael Boyce-Jacino, Orchid Biocomputer Dr. Francois Chatelain, ProtoGene Dr. Vladimir Efimov, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry Dr. Glenn McGall, Affymetrix Dr. Andrei Mirzabekov, Argonne National Laboratory Dr. Edwin Southern, Oxford University Monday Morning: Mechanisms and Pharmacology Dr. Sudhir Agrawal, Hybridon Dr. Susan Freier, Isis Pharmaceuticals Dr. Jean-Louis Imbach, Université de Montpellier Dr. Rudolph L. Juliano, University of North Carolina Dr. Ülo Langel, Stockholm University Dr. Jean-Jacques Toulmé, Université Victor Segalen Monday Evening: Preclinical Trials Dr. Esther Chang, Georgetown University Dr. Patrick Iversen, AVI BioPharma Dr. Daniela Verthelyi, Food and Drug Administration Dr. Valentin Vlassov, Novosibirsk Institute of Bioorganic Chemistry Dr. Claes Wahlestedt, Karolinska Institutet Dr. Paul Zamecnik, Massachusetts General Hospital Tuesday Morning: Gene Therapy Vectors Dr. Dennis Klinman, Food and Drug Administration Dr. Eric Kmiec, University of Delaware Dr. Daniel Mercola, Sidney Kimmel Cancer Center Dr. Arun Srivastava, Indiana University School of Medicine Dr. Richard Vile, Mayo Clinic Dr. Eric Wickstrom, Thomas Jefferson University Tuesday Evening: Clinical Trials Dr. Yoon Cho-Chung, National Cancer Institute Dr. John Rossi, City of Hope Dr. Branimir Sikic, Stanford University Dr. Alison Stopeck, University of Arizona Dr. Stephen Swisher, University of Texas Dr. Nissim Usman, Ribozyme Pharmaceuticals Conference Location: Hilton Clearwater Beach Resort 400 Mandalay Avenue Clearwater Beach, Florida 33767 800-753-3954 or 727-461-3222; fax=727-446-1583 Conference Travel: Nancy Volk, Naylor Travel Group 111 E. Lancaster Avenue, Devon, Pennsylvania 19333 800-355-7901 or 610-964-7900; fax=610-964-9101 Conference Supporters: Glen Research Research Genetics Gene Tools Novartis TriLink BioTechnologies Amersham Pharmacia Biotech International Union of Biochemistry and Molecular Biology Rhône-Poulenc Rorer Inex Pharmaceuticals US National Institutes of Health Annovis PE Biosystems Berry & Associates Integrated DNA Technologies Hybridon Good luck with your work. Sincerely, Eric Wickstrom Professor Eric Wickstrom Department of Microbiology and Immunology Thomas Jefferson University 1025 Walnut Street, Suite 420 Philadelphia PA 19107-5083 voice: 215-955-4578 fax: 215-955-4580, 215-923-9214, 815-352-0382 http://tesla.jci.tju.edu Millennium Conference on Nucleic Acid Therapeutics, 8-11 January 2000: http://tesla.jci.tju.edu/millennium.html .